Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Pharma
Apellis hit with yet another eye drug snub in Europe
Amid a parade of regulatory endorsements in Europe, Apellis’ ophthalmology prospect pegcetacoplan has been left in the cold once again.
Fraiser Kansteiner
Sep 20, 2024 10:06am
BMJ says newer migraine drugs less effective than older triptans
Sep 19, 2024 11:32am
Meet the winners of the 2024 Fierce Pharma Marketing Awards
Sep 12, 2024 9:00am
Alnylam sees Amvuttra as potential standard of care in ATTR-CM
Aug 30, 2024 10:06am
AbbVie's Ubrelvy fares well warding off migraines in study
Aug 29, 2024 11:58am
GSK secures favorable Zantac court ruling in Delaware
Aug 28, 2024 8:10am
